Cargando…
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
Autores principales: | Santarsieri, Anna, Sturgess, Katherine, Brice, Pauline, Menne, Tobias F., Osborne, Wendy, Creasey, Thomas, Ardeshna, Kirit M., Behan, Sarah, Bhuller, Kaljit, Booth, Stephen, Chavda, Nikesh, Collins, Graham P., Culligan, Dominic, Cwynarski, Kate, Davies, Andrew, Dutton, David, Furtado, Michelle, Gallop-Evans, Eve, Hodson, Andrew, Hopkins, David, Hsu, Hannah, Iyengar, Sunil, Jones, Stephen G., Linton, Kim, Lomas, Oliver, Martinez-Calle, Nicolas, Mathur, Abhinav, Mckay, Pamela, Nagumantry, Sateesh K., O’Mahony, Deidre, Phillips, Beth, Phillips, Neil, Rudge, John F., Shah, Nimish, Stafford, Gwyneth, Sternberg, Alex, Trickey, Rachel, Uttenthal, Benjamin J., Wetherall, Natasha, Mcmillan, Andrew K., Follows, George A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621483/ http://dx.doi.org/10.1097/01.HS9.0000890628.71833.65 |
Ejemplares similares
-
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
por: Dragičević, Ida Hude, et al.
Publicado: (2022) -
P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
por: Mocikova, Heidi, et al.
Publicado: (2022) -
P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
por: Dorokhina, Elena, et al.
Publicado: (2022) -
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
por: Russell, James, et al.
Publicado: (2021) -
Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
por: Suwanban, Tawatchai, et al.
Publicado: (2023)